Careers  |  Sign In  |  Register

Latest in HIV/AIDS

An article in The New York Times reports that a daily dose of isoniazid, a generic antibiotic, can "fend off a lethal bout of tuberculosis in people with H.I.V., according to a large new study." The study found that "a daily isoniazid pill reduced deaths and active TB cases by 31 percent among 12,816...
Bloomberg News reports that GlaxoSmithKline "won U.S. regulatory approval for a daily pill against the deadly HIV infection" developed by ViiV Healthcare. The pill, called Tivicay, uses an “integrase strand transfer inhibitor that interferes with the enzymes necessary for HIV to multiply" in combination...

Healthcare Regulation

FDA Removes HIV Drug Hurdle

Bloomberg News reports that the United States Food and Drug Administration (FDA) is "making it easier to develop new HIV drugs" in an effort to help long-term HIV sufferers who have become resistant to available treatment options. Many HIV patients rely on drugs that, "for the most part, came on the market...